Latest news with #TSH
Hans India
a day ago
- Health
- Hans India
Breakthrough Minimally Invasive Procedure Cures Rare Thyroid Disorder Without Scars
Bengaluru: A 41-year-old woman Sudha (name changed), admitted to Aster Whitefield, underwent a complex and uncommon procedure where a rare form of retrosternal goitre (a thyroid swelling) was successfully treated using a combination of thyroid artery embolization (TAE) and Radiofrequency ablation (RFA). This minimally invasive approach helped the patient to get rid of the swelling that had extended deep into the chest and avoid a risky open surgery, thereby assuring her a speedy recovery. The patient, a professor at a university, had been having trouble breathing when in a recumbent position, as well as palpable neck swelling. Although retrosternal goiters typically present in elderly individuals, predominantly women over 50, this case was exceptional due to the patient's young age and the remarkable extent of the goiter's growth, reaching as far as the aortic arch. The cause of multinodular goiters in younger women, may arise secondary to iodine deficiency, hereditary goiter syndromes, or prolonged stimulation by thyroid-stimulating hormone (TSH), although we couldn't establish cause in this patient. The case was handled by interventional radiology team comprising Dr. Dheeraj Shyam, Lead Consultant – Interventional Radiology, and Dr. Madhushree, Specialist – Interventional Radiology, of Aster Whitefield Hospital using a minimally invasive procedure- Thyroid artery embolisation. A Preliminary CT angiogram and an ultrasound was done. It revealed that the enlarged multinodular thyroid was deriving blood supply from two pairs of thyroid arteries namely inferior and superior thyroid arteries on either sides. In this case the predominant arterial supply of the goitre was from right inferior thyroid artery. The interventional radiology team performed a minimally invasive procedure called thyroid artery embolisation. The procedure significantly reduced the size of the goiter overtime alleviating the patient's symptoms. Real-time imaging was employed, and three out of four arteries were occluded using medically safe particles (PVA particles), effectively cutting off the blood supply thus causing the goiter to shrink. RFA was a reinforcement strategy for one of the small nodule reported as Bethesda III, which again was a minimally invasive method. 'Thyroid artery embolization' is a precise and targeted procedure, beneficial for patients with large multinodular goitre and retrosternal goiters who are either unsuitable for surgery or prefer to avoid it. In this case, the dominant arterial supply from the right inferior thyroid artery allowed us to safely perform embolisation using polyvinyl alcohol particles. This significantly reduced thyroid vascularity and size. In India, thyroid artery embolization (TAE) and radiofrequency ablation (RFA) for benign thyroid conditions, such as retrosternal goitre, are not yet widely available and remain limited to specialized tertiary care centers, said Dr. Dheeraj Shyam, Lead Consultant – Interventional Radiology at Aster Whitefield Hospital. Careful planning was essential due to the proximity of the goitre to the aortic arch and mediastinal structures. The use of real-time ultrasound and fluroscopy guidance helped us precisely target the artery and nodule. With embolization and RFA, we achieved optimal volume reduction and symptom relief, while sparing the patient the risks of open neck surgery,' said Dr. Madhushree, Specialist Interventional radiologist, Aster Whitefield Hospital. The patient responded well, reporting major relief in breathing within days. A follow-up scan after four weeks revealed the thyroid was smaller and less vascular. With no complications and very little stay in hospital, she returned to normal life shortly with few follow-ups scheduled to check on her recovery.
Yahoo
3 days ago
- Business
- Yahoo
If EPS Growth Is Important To You, TSH (Catalist:KUH) Presents An Opportunity
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. Unfortunately, these high risk investments often have little probability of ever paying off, and many investors pay a price to learn their lesson. A loss-making company is yet to prove itself with profit, and eventually the inflow of external capital may dry up. So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like TSH (Catalist:KUH). While this doesn't necessarily speak to whether it's undervalued, the profitability of the business is enough to warrant some appreciation - especially if its growing. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. TSH's Earnings Per Share Are Growing If a company can keep growing earnings per share (EPS) long enough, its share price should eventually follow. So it makes sense that experienced investors pay close attention to company EPS when undertaking investment research. TSH's shareholders have have plenty to be happy about as their annual EPS growth for the last 3 years was 54%. Growth that fast may well be fleeting, but it should be more than enough to pique the interest of the wary stock pickers. It's often helpful to take a look at earnings before interest and tax (EBIT) margins, as well as revenue growth, to get another take on the quality of the company's growth. TSH shareholders can take confidence from the fact that EBIT margins are up from 5.9% to 8.4%, and revenue is growing. Both of which are great metrics to check off for potential growth. In the chart below, you can see how the company has grown earnings and revenue, over time. For finer detail, click on the image. View our latest analysis for TSH Since TSH is no giant, with a market capitalisation of S$4.3m, you should definitely check its cash and debt before getting too excited about its prospects. Are TSH Insiders Aligned With All Shareholders? Theory would suggest that it's an encouraging sign to see high insider ownership of a company, since it ties company performance directly to the financial success of its management. So we're pleased to report that TSH insiders own a meaningful share of the business. To be exact, company insiders hold 80% of the company, so their decisions have a significant impact on their investments. This makes it apparent they will be incentivised to plan for the long term - a positive for shareholders with a sit and hold strategy. Valued at only S$4.3m TSH is really small for a listed company. So despite a large proportional holding, insiders only have S$3.4m worth of stock. That's not a huge stake in absolute terms, but it should help keep insiders aligned with other shareholders. It means a lot to see insiders invested in the business, but shareholders may be wondering if remuneration policies are in their best interest. Our quick analysis into CEO remuneration would seem to indicate they are. Our analysis has discovered that the median total compensation for the CEOs of companies like TSH with market caps under S$257m is about S$479k. TSH offered total compensation worth S$331k to its CEO in the year to December 2024. That is actually below the median for CEO's of similarly sized companies. CEO compensation is hardly the most important aspect of a company to consider, but when it's reasonable, that gives a little more confidence that leadership are looking out for shareholder interests. It can also be a sign of a culture of integrity, in a broader sense. Is TSH Worth Keeping An Eye On? TSH's earnings per share growth have been climbing higher at an appreciable rate. An added bonus for those interested is that management hold a heap of stock and the CEO pay is quite reasonable, illustrating good cash management. The sharp increase in earnings could signal good business momentum. Big growth can make big winners, so the writing on the wall tells us that TSH is worth considering carefully. You still need to take note of risks, for example - TSH has 2 warning signs we think you should be aware of. Although TSH certainly looks good, it may appeal to more investors if insiders were buying up shares. If you like to see companies with more skin in the game, then check out this handpicked selection of Singaporean companies that not only boast of strong growth but have strong insider backing. Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Hans India
5 days ago
- Health
- Hans India
Minimally invasive procedure cures rare thyroid disorder without scars
Bengaluru: A 41-year-old woman Sudha (name changed), admitted to Aster Whitefield, underwent a complex and uncommon procedure where a rare form of retrosternal goitre (a thyroid swelling) was successfully treated using a combination of thyroid artery embolization (TAE) and Radiofrequency ablation (RFA). This minimally invasive approach helped the patient to get rid of the swelling that had extended deep into the chest and avoid a risky open surgery, thereby assuring her a speedy recovery. The patient, a Professor at a university, had been having trouble breathing when in a recumbent position, as well as palpable neck swelling. Although retrosternal goiters typically present in elderly individuals, predominantly women over 50, this case was exceptional due to the patient's young age and the remarkable extent of the goiter's growth, reaching as far as the aortic arch. The cause of multinodular goiters in younger women, may arise secondary to iodine deficiency, hereditary goiter syndromes, or prolonged stimulation by thyroid-stimulating hormone (TSH), although we couldn't establish cause in this patient.
Focus Malaysia
24-06-2025
- Business
- Focus Malaysia
Palm oil sector faces ESG pressure amid global scrutiny
THE oil palm plantation sector has long been linked to deforestation, greenhouse gas (GHG) emissions, labour exploitation, and land rights violations. These longstanding issues have resulted in: (i) Increased global scrutiny and the introduction of stricter regulations, particularly from major importing regions such as the European Union and the United States. (ii) A noticeable shift in demand from buyers and consumers (especially in these regions) toward sustainably produced palm oil. (iii) The growing integration of ESG criteria into funding and investment decisions by financial institutions, including both lenders and investors. 'In response, planters have intensified efforts to adopt and integrate ESG principles across their operations,' said Hong Leong Investment Bank. Beyond rising ESG adoption, the level of ESG disclosure among planters has improved over time, spurred by both mandatory and market-driven requirements. Notable examples include the EU Deforestation Regulation (EUDR), which requires enhanced traceability and data systems; Task Force on Climate-Related Financial Disclosures (TCFD) reporting, and sustainability disclosures mandated by Bursa Malaysia. Key elements within the Environmental pillar (particularly GHG emissions, and water management) are critical in in assessing how planters interact with and impact the natural environment. 4 out of 7 planters recorded lower GHG intensity (namely HS Plant, JPG, KLK and SDG). These improvements stemmed from various reduction initiatives, such as the installation of biogas plants and filter belt press, the purchase of green energy, and the use of by-products like palm kernel shell (PKS), etc. In terms of water intensity, 7 out of 8 planters achieved lower water intensity in FY24, signalling more efficient water usage and improved water management practices across operations. While progress under the Social pillar is more difficult to quantify due to its qualitative nature, many planters have shown clear commitment to addressing key social concerns. This is reflected in initiatives such as improved labour practices, enhanced workers' welfare, community engagement programmes, and efforts to uphold human rights across their operations and supply chains. Governance practices among planters showed uneven progress in FY24, particularly in board independence and gender diversity. In terms of board independence, all planters met the minimum requirement under the Malaysian Code on Corporate Governance (MCCG) i.e. at least 50% independent board representation. HS Plant and KLK improved their board independence (from 40-44% in FY23 to 56-60% in FY24). In contrast, IOI and TSH saw declines (from 67% and 56% in FY23 to 57% and 50% in FY24, respectively). Gender diversity, on the other hand, showed mixed progress in FY24. While HS Plant, KLK, and TSH recorded higher female board representation in FY24, FGV and SDG experienced declines. Notably, 4 out of 8 planters under coverage still fall short of the MCCG's recommendation of 30% female representation on the board. YTD, CPO price averaged at RM4,399/mt. We maintain our 2025-26 CPO price projections of RM4,000/mt and RM3,800/mt for now, pending a review (with slight upside bias). Maintain Neutral on the sector, given the absence of clear demand catalyst (at least for now). For exposure, our top picks are SDG (BUY; TP: RM5.17), JPG (BUY; TP: RM1.35) and IOI (BUY; TP: RM4.24). —June 24, 2025 Main image: Tasting Table
Time of India
17-06-2025
- Sport
- Time of India
Budding cricketers to get tips from Piyush Chawla in spl camp
Kanpur: Veteran leg spinner Piyush Chawla, who was part of India's two World Cup winning campaigns, will give tips to budding cricketers in a special coaching camp organised by the Sports Hub (TSH) to be held from June 19 to June 25. Tired of too many ads? go ad free now Aligarh (UP) born Piyush Chawla was a member of India's T-20 and ODI World Cup winning squad in 2007 and 2011 respectively. He represented India in three tests, 25 ODIs and 7 T-20 matches and captured 43 wickets across the three formats of the game. He had taken retirement from all formats of the cricket on June 6 this year. Addressing the media, former Ranji Trophy captain Shashikant Khandekar, presently coach at the TSH, said that it would be a boon for the city cricketers that a world class spinner would give them tips and share his experiences in the camp in which around 160 children would participate. Khandekar stated that all had witnessed that spinners, especially leg spinners, were playing a significant role in all formats of cricket including T-20. Shashikant said that Piyush will stay in the camp for three days, thereafter he and former Ranji Trophy player Mohd Amir would take charge of the camp which would be held in morning and evening sessions. RP Singh, director sports, stated that the TSH would conduct more such camps and give opportunities to local talent to meet the international level players and learn from them.
